Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
J Oral Rehabil ; 34(8): 590-9, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17650169

RESUMO

The literature contains numerous observations on the significance of systemic disorders as contraindications to dental endosseous implant treatment, but the justification for these statements is often apparently allegorical. Although implants are increasingly used in healthy patients, their appropriateness in medically compromised patients is less equivocal. Perhaps surprisingly, the evidence of their efficacy in these groups of patients is quite sparse. Indeed, there are few if any randomized controlled trials (RCTs) in this field. Furthermore, any health risks from the placement of implants are unclear. We review the current evidence for the risks associated with endosseous implants in a range of systemic disorders. There is clearly a need for prospective systematic trials. The degree of disease-control may be far more important that the nature of the disorder itself, and individualized assessment, including the medical condition, quality of life and life expectancy is indicated. The benefits of implants to many of these patients may outweigh any risks. However, proper informed consent is mandatory.


Assuntos
Assistência Odontológica para Doentes Crônicos/métodos , Implantação Dentária Endóssea/métodos , Implantes Dentários , Hospedeiro Imunocomprometido , Alcoolismo/complicações , Doenças Ósseas/complicações , Complicações do Diabetes , Transtornos Hemorrágicos/complicações , Humanos , Neoplasias/complicações , Neoplasias/terapia
2.
Oral Dis ; 12(5): 487-92, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16910920

RESUMO

BACKGROUND: Opinions, knowledge, behaviours and attitudes of general dental practitioners on oral cancer prevention and detection have been reported from many countries. However, experiences and skills of oral cancer detection have not been evaluated systematically. OBJECTIVE: To obtain information on behaviours of screening and ability to correctly detect oral cancer and precancer among general dentists (GDP) in North-western Spain. SUBJECTS AND METHODS: Thirty-two randomly selected GDPs completed questionnaires and then classified 50 projected images of clinical lesions, into cancer, precancer or benign lesions. RESULTS: 87.5% reported conducting routine oral examinations, 84.4% provided routine advice to their subjects for risk modifications and 84.4% claimed to biopsy a suspected oral mucosal lesion that they detected in practice. In a quasi research setting using clinical slides, the sensitivity of visual diagnosis of a cancerous lesion was 61.4% and precancer 59.5%. The diagnostic accuracy reported here is lower than what is already reported by evaluation of published screening programmes by dentists. CONCLUSIONS: Our data from Spain suggest a need for improving the diagnostic ability of GDPs in the visual detection of oral cancer/precancer by strengthening continuing professional education.


Assuntos
Odontologia Geral/normas , Neoplasias Bucais/diagnóstico , Competência Clínica/normas , Humanos , Neoplasias Bucais/prevenção & controle , Sensibilidade e Especificidade , Espanha , Inquéritos e Questionários
3.
Oral Dis ; 11(4): 230-5, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15984954

RESUMO

Saliva can contain a range of infectious agents and, despite several antimicrobial mechanisms, transmission of these can occur. Hepatitis C virus (HCV) is of increasing importance, and HCV is transmitted by unknown routes as well as by the percutaneous route and sexual contact. Contact with blood or other body fluids may be responsible, as may be receipt of unscreened blood or blood product transfusions. HCV-RNA can be detected by the polymerase chain reaction which also shows that HCV may be present in the saliva of HCV-infected patients. This might provide an argument for the possible transmission of HCV via contaminated saliva. Epidemiological studies however, suggest that the infective capacity of HCV viral particles in saliva is low, but it has not been possible to determine their infective potential. Moreover, HCV-specific receptors have not been defined on oral epithelial cells, nor has the role of host defence mechanisms been determined. New experimental animal models and the recently described infectious HCV pseudoparticles, capable of simulating HCV replication in vitro, could be useful in establishing any role of saliva in the transmission of HCV infection.


Assuntos
Hepatite C/transmissão , Saliva/virologia , Animais , Hepacivirus/isolamento & purificação , Humanos , Mucosa Bucal/virologia , RNA Viral/análise
5.
Artigo em Inglês | MEDLINE | ID: mdl-11174574

RESUMO

An unusual case of synchronous squamous cell carcinoma and leiomyosarcoma of the oral cavity is reported in a patient without any identified environmental risk or predisposing factors. The invasive squamous cell carcinoma involved the tongue, whereas the leiomyosarcoma was located in the soft palate. No immunostaining was found for human papillomavirus or Epstein-Barr virus, and in situ hybridization showed negativity for human papillomavirus DNA within the tumor cells. Alterations of bcl -2, c-erb -b2 and Rb oncoproteins were not found immunohistochemically. Overexpression of p53 was detected by immunohistochemistry in both tumors, but p53 gene mutations were not found by polymerase chain reaction. Neither loss of heterozygosity of p53 nor microsatellite instability was detected in this patient. The smooth muscle nature of the leiomyosarcoma was confirmed by immunohistochemical methods. To our knowledge, synchronous smooth muscle and epithelial oral tumors have not previously been reported.


Assuntos
Carcinoma de Células Escamosas/patologia , Leiomiossarcoma/patologia , Neoplasias Primárias Múltiplas/patologia , Neoplasias Palatinas/patologia , Neoplasias da Língua/patologia , Idoso , Humanos , Imuno-Histoquímica , Masculino , Proteína Supressora de Tumor p53/análise
8.
Artigo em Inglês | MEDLINE | ID: mdl-7614179

RESUMO

A prospective study to assess the efficacy of fluconazole in oropharyngeal candidiasis in patients with HIV was conducted. A cohort of 30 HIV-positive persons with clinical and microbiologic confirmed oropharyngeal candidiasis (Candida albicans > 1000 CFU/ml) received fluconazole 100 mg daily for 7 days. In vitro antifungal susceptibility tests demonstrated a lack of fluconazole resistances. Cultures of mouth swabs were performed at the end of therapy and 2 weeks later. There was a clinical and microbiologic cure in 26 patients (87%). In 10 of these 26, cultures remained negative after 2 weeks; most of them had CD4 lymphocyte count > 400/ml. In the other 16 patients (53%), cultures showed a microbiologic relapse 2 weeks after treatment. In spite of clinical improvement, treatment failure was observed in four patients, all of them with CD4 lymphocyte count < 50 ml.


Assuntos
Candidíase Bucal/tratamento farmacológico , Fluconazol/uso terapêutico , Infecções por HIV/complicações , Contagem de Linfócito CD4 , Candida albicans/efeitos dos fármacos , Candida albicans/isolamento & purificação , Candidíase Bucal/etiologia , Contagem de Colônia Microbiana , Fluconazol/farmacologia , Humanos , Testes de Sensibilidade Microbiana , Estudos Prospectivos , Recidiva , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...